UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 310

Sortiert nach

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers

The New England journal of medicine, 2009-07, Vol.361 (2), p.123-134

2009

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic Therapy in Oncology

The oncologist (Dayton, Ohio), 2006-10, Vol.11 (9), p.1034-1044

2006

Link zum Volltext

Verfügbarkeit prüfen

Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P‐glycoprotein)

The oncologist (Dayton, Ohio), 2007-08, Vol.12 (8), p.927-941

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Clinical cancer research, 2004-06, Vol.10 (11), p.3717-3727

2004

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

Clinical cancer research, 2011-05, Vol.17 (10), p.3455-3468

2011

Link zum Volltext

Verfügbarkeit prüfen

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

International journal of cancer, 2013-05, Vol.132 (10), p.2439-2447

2013

Link zum Volltext

Verfügbarkeit prüfen

Electrospray Ionization Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry as a Tool to Distinguish the Lot-to-Lot Heterogeneity in N-Glycosylation Profile of the Therapeutic Monoclonal Antibody Trastuzumab

Journal of the American Society for Mass Spectrometry, 2009-11, Vol.20 (11), p.2021-2033

2009

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of biomarkers to monitor therapeutic response in leishmaniasis

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.1-14

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4540-4544

2017

Link zum Volltext

Verfügbarkeit prüfen

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2512-2519

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

World journal of gastroenterology : WJG, 2006-03, Vol.12 (10), p.1536

2006

Link zum Volltext

Verfügbarkeit prüfen

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

British journal of cancer, 2021-02, Vol.124 (4), p.728-735

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients

Clinical cancer research, 2007-06, Vol.13 (11), p.3276-3285

2007

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab

The oncologist (Dayton, Ohio), 2010-08, Vol.15 (8), p.819-825

2010

Link zum Volltext

Verfügbarkeit prüfen

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

Clinical cancer research, 2004-05, Vol.10 (10), p.3386-3395

2004

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutations as Predictive Biomarker for Response to Anti‐EGFR Monoclonal Antibodies

The oncologist (Dayton, Ohio), 2017-07, Vol.22 (7), p.864-872

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

Clinical cancer research, 2006-10, Vol.12 (19), p.5786-5793

2006

Link zum Volltext

Verfügbarkeit prüfen

Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants

The Plant cell, 2017-11, Vol.29 (11), p.2831-2853

2017

Link zum Volltext

Verfügbarkeit prüfen

A phosphotyrosine switch regulates organic cation transporters

Nature communications, 2016-03, Vol.7 (1), p.10880-10880, Article 10880

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of reduced‐dose fluoropyrimidine therapy in patients carrying the DPYD2A variant: A matched pair analysis

International journal of cancer, 2019-05, Vol.144 (9), p.2347-2354

2019

Link zum Volltext

Verfügbarkeit prüfen

Severe Skin Toxicity in Pediatric Oncology Patients Treated with Voriconazole and Concomitant Methotrexate

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2878-2881

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Clinical cancer research, 2011-03, Vol.17 (5), p.1131-1139

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer

British journal of cancer, 2020-04, Vol.122 (8), p.1166-1174

2020

Link zum Volltext

Verfügbarkeit prüfen

EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (6), p.855-862

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 310

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(298)
Mit Volltextzugriff
(298)

Publikationsform

Artikel
(310)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(228)
Humans
(193)
Oncology
(160)
Female
(131)
Male
(102)
Middle Aged
(98)
Adult
(87)
Aged
(87)
Biological And Medical Sciences
(83)
Medical Sciences
(83)
Pharmacology. Drug Treatments
(66)
Neoplasms - Drug Therapy
(62)
Antineoplastic Agents
(56)
Tumors
(46)
Pharmacology & Pharmacy
(44)
Animals
(43)
Antineoplastic Agents - Pharmacokinetics
(37)
Dose-Response Relationship, Drug
(34)
Treatment Outcome
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers

Photodynamic Therapy in Oncology

Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P‐glycoprotein)

A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

Electrospray Ionization Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry as a Tool to Distinguish the Lot-to-Lot Heterogeneity in N-Glycosylation Profile of the Therapeutic Monoclonal Antibody Trastuzumab

Systematic review of biomarkers to monitor therapeutic response in leishmaniasis

Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer

Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients

Bevacizumab

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

BRAF Mutations as Predictive Biomarker for Response to Anti‐EGFR Monoclonal Antibodies

Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants

A phosphotyrosine switch regulates organic cation transporters

Effectiveness and safety of reduced‐dose fluoropyrimidine therapy in patients carrying the DPYD2A variant: A matched pair analysis

Severe Skin Toxicity in Pediatric Oncology Patients Treated with Voriconazole and Concomitant Methotrexate

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer

EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors

Aktive Filter

Suchergebnisse filtern